TD Asset Management’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Hold |
545,388
| – | – | ﹤0.01% | 1111 |
|
|
2025
Q1 | $796K | Hold |
545,388
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q4 | $1.16M | Sell |
545,388
-131,752
| -19% | -$281K | ﹤0.01% | 1095 |
|
|
2024
Q3 | $1.97M | Sell |
677,140
-122,200
| -15% | -$356K | ﹤0.01% | 1052 |
|
|
2024
Q2 | $1.86M | Buy |
799,340
+361,904
| +83% | +$843K | ﹤0.01% | 1024 |
|
|
2024
Q1 | $1.96M | Buy |
437,436
+199,600
| +84% | +$892K | ﹤0.01% | 1031 |
|
|
2023
Q4 | $763K | Hold |
237,836
| – | – | ﹤0.01% | 1236 |
|
|
2023
Q3 | $754K | Buy |
237,836
+38,357
| +19% | +$122K | ﹤0.01% | 1196 |
|
|
2023
Q2 | $991K | Buy |
199,479
+25,800
| +15% | +$128K | ﹤0.01% | 1134 |
|
|
2023
Q1 | $858K | Hold |
173,679
| – | – | ﹤0.01% | 1163 |
|
|
2022
Q4 | $1.09M | Buy |
173,679
+9,000
| +5% | +$56.6K | ﹤0.01% | 1125 |
|
|
2022
Q3 | $1.7M | Buy |
164,679
+36,706
| +29% | +$379K | ﹤0.01% | 1053 |
|
|
2022
Q2 | $1.46M | Buy |
127,973
+5,600
| +5% | +$63.8K | ﹤0.01% | 1098 |
|
|
2022
Q1 | $1.12M | Buy |
122,373
+13,200
| +12% | +$120K | ﹤0.01% | 1212 |
|
|
2021
Q4 | $1.63M | Sell |
109,173
-2,192
| -2% | -$32.7K | ﹤0.01% | 1180 |
|
|
2021
Q3 | $2.86M | Buy |
111,365
+19,689
| +21% | +$506K | ﹤0.01% | 977 |
|
|
2021
Q2 | $2.01M | Buy |
91,676
+10,171
| +12% | +$223K | ﹤0.01% | 1094 |
|
|
2021
Q1 | $2.88M | Buy |
81,505
+3,632
| +5% | +$128K | ﹤0.01% | 995 |
|
|
2020
Q4 | $1.97M | Buy |
77,873
+192
| +0.2% | +$4.85K | ﹤0.01% | 1043 |
|
|
2020
Q3 | $2.93M | Sell |
77,681
-4,800
| -6% | -$181K | ﹤0.01% | 829 |
|
|
2020
Q2 | $3.53M | Buy |
82,481
+28,206
| +52% | +$1.21M | 0.01% | 735 |
|
|
2020
Q1 | $1.06M | Sell |
54,275
-3,600
| -6% | -$70K | ﹤0.01% | 981 |
|
|
2019
Q4 | $1.5M | Hold |
57,875
| – | – | ﹤0.01% | 995 |
|
|
2019
Q3 | $1.58M | Hold |
57,875
| – | – | ﹤0.01% | 961 |
|
|
2019
Q2 | $1.55M | Buy |
57,875
+32,232
| +126% | +$865K | ﹤0.01% | 967 |
|
|
2019
Q1 | $741K | Buy |
25,643
+600
| +2% | +$17.3K | ﹤0.01% | 1099 |
|
|
2018
Q4 | $674K | Buy |
+25,043
| New | +$674K | ﹤0.01% | 1154 |
|